A murine, bispecific monoclonal antibody simultaneously recognizing β-Glucan and MP65 determinants in Candida species

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Zito, Andrea ^a   Bromuro, Carla ^b   Mandili, Giorgia ^a,c   Chiani, Paola ^b   Horenstein, Alberto L ^a   Malavasi, Fabio ^a   Cauda, Roberto ^d   Cassone, Antonio ^e   Torosantucci, Antonella ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BETA D GLUCAN; 1,6 BETA D GLUCAN; BETA GLUCAN; BIOLOGICAL MARKER; LAMINARAN; MANNOPROTEIN; MONOCLONAL ANTIBODY; MP65 BGLU MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; BISPECIFIC ANTIBODY; EPITOPE; FUNGAL PROTEIN; FUNGUS ANTIBODY; FUNGUS ANTIGEN; MANNOPROTEINS; MEMBRANE PROTEIN;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; NONHUMAN; PROTEIN BINDING; PROTEIN PURIFICATION; PROTEIN SECRETION; SENSITIVITY ANALYSIS; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; CANDIDA; CANDIDIASIS, INVASIVE; HUMAN; IMMUNOLOGY; MOUSE; SEROLOGY; VALIDATION STUDY;

ANIMALS; ANTIBODIES, BISPECIFIC; ANTIBODIES, FUNGAL; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, FUNGAL; BETA-GLUCANS; BIOMARKERS; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS, INVASIVE; FUNGAL PROTEINS; HUMANS; IMMUNODOMINANT EPITOPES; MEMBRANE GLYCOPROTEINS; MICE; SEROLOGIC TESTS;

EID: 84959244365     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148714     Document Type: Article

References (47)

1. Delaloye J, Calandra T. Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence. 2014; 5: 161-169. doi:10.4161/viru.26187PMID: 24157707.
2. Clancy CJ, Nguyen MH. Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis. 2013; 56: 1284-1292. doi:10.1093/cid/cit006PMID: 23315320.
3. Moran C, Grussemeyer CA, Spalding JR, Benjamin DK Jr, Reed SD. Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections. Am J Infect Control. 2010; 38: 78-80. doi:10.1016/j.ajic.2009.06.014 PMID: 19836856.
4. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: A potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005; 49: 3640-3645. PMID: 16127033.
5. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study. Clin Infect Dis. 2006; 43: 25-31. PMID: 16758414.
6. De Monte L, Nistico P, Tecce R, Dellabona P, Momo M, Tarditi L, et al. Gene transfer by retrovirusderived shuttle vectors in the generation of murine bispecific MAbs. Dev Biol Stand. 1990; 71: 15-22. PMID: 2401381.
7. Malavasi F, De Monte LB, Funaro A, Magrini E, Bonino LD, Momo M, et al. Cell surface receptors and bispecific monoclonal antibodies: the link between basic science and medical oncology. Year Immunol. 1993; 7: 74-80. PMID: 8396823.
8. Horenstein AL, Poiesi C, DeMonte L, Camagna M, Mariani M, Albertini A, et al. Real-time kinetic analysis applied to the production of bispecific monoclonal antibodies for radioimmunodetection of cancer. Int J Clin Lab Res. 1993; 23: 199-205. PMID: 8123875.
9. Nistico P, Mortarini R, De Monte LB, Mazzocchi A, Mariani M, Malavasi F, et al. Cell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanoma. J Clin Invest. 1992; 90: 1093-1099. PMID: 1387883.
10. DeMonte LB, Nistico P, Tecce R, Dellabona P, Momo M, Anichini A, et al. Gene transfer by retrovirusderived shuttle vectors in the generation of murine bispecific monoclonal antibodies. Proc Natl Acad Sci U S A. 1990; 87: 2941-2945. PMID: 2326256.
11. Kontermann RE. Dual targeting strategies with bispecific antibodies. MAbs. 2012; 4: 182-197. doi:10.4161/mabs.4.2.19000 PMID: 22453100.
12. Byrne H, Conroy PJ, Whisstock JC, O'Kennedy RJ. A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications. Trends Biotechnol. 2013; 31: 621-632. doi:10.1016/j.tibtech.2013.08.007PMID: 24094861.
13. Torosantucci A, Chiani P, Bromuro C, De Bernardis F, Palma AS, Liu Y, et al. Protection by anti-betaglucan antibodies is associated with restricted beta-1, 3 glucan binding specificity and inhibition of fungal growth and adherence. PLoS One. 2009; 4: e5392. doi:10.1371/journal.pone.0005392 PMID: 19399183.
14. Torosantucci A, Bromuro C, Chiani P, De Bernardis F, Berti F, Galli C, et al. A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med. 2005; 202: 597-606. PMID: 16147975.
15. Torosantucci A, Bromuro C, Gomez MJ, Ausiello CM, Urbani F, Cassone A. Identification of a 65-kDa mannoprotein as a main target of human cell-mediated immune response to Candida albicans. J Infect Dis. 1993; 168: 427-435. PMID: 8335981.
16. Gomez MJ, Torosantucci A, Arancia S, Maras B, Parisi L, Cassone A. Purification and biochemical characterization of a 65-kilodalton mannoprotein (MP65), a main target of anti-Candida cell-mediated immune responses in humans. Infect Immun. 1996; 64: 2577-2584. PMID: 8698482.
17. Horenstein AL, Durelli I, Malavasi F. Purification of clinical-grade monoclonal antibodies by chromatographic methods. Methods Mol Biol. 2005; 308: 191-208. PMID: 16082036.
18. Horenstein AL, Crivellin F, Funaro A, Said M, Malavasi F. Design and scaleup of downstream processing of monoclonal antibodies for cancer therapy: from research to clinical proof of principle. J Immunol Methods. 2003; 275: 99-112. PMID: 12667674.
19. Carlring J, De Leenheer E, Heath AW. A novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studies. PLoS One. 2011; 6: e22533. doi:10.1371/journal.pone.0022533 PMID: 21811628.
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227: 680-685. PMID: 5432063.
21. Ouchterlony O. Antigen-antibody reactions in gels. IV. Types of reactions in coordinated systems of diffusion. Acta Pathol Microbiol Scand. 1953; 32: 230-240. PMID: 13079779.
22. Candida Genome Database. Available: http://www.candidagenome.org/.
23. Wang G, Marquardt RR, Xiao H, Zhang Z. Development of a 96-well enzyme-linked solid-phase assay for beta-glucanase and xylanase. J Agric Food Chem. 1999; 47: 1262-1267. PMID: 10552447.
24. Berzaghi R, Colombo AL, Machado AM, de Camargo ZP. New approach for diagnosis of candidemia based on detection of a 65-kilodalton antigen. Clin Vaccine Immunol. 2009; 16: 1538-1545. doi:10.1128/CVI.00176-09 PMID: 19776195.
25. Tarditi L, Camagna M, Parisi A, Vassarotto C, DeMonte LB, Letarte M, et al. Selective high-performance liquid chromatographic purification of bispecific monoclonal antibodies. J Chromatogr. 1992; 599: 13-20. PMID: 1618986.
26. Bromuro C, Torosantucci A, Gomez MJ, Urbani F, Cassone A. Differential release of an immunodominant 65 kDa mannoprotein antigen from yeast and mycelial forms of Candida albicans. J Med Vet Mycol. 1994; 32: 447-459. PMID: 7738727.
27. DiGiandomenico A, Keller AE, Gao C, Rainey GJ, Warrener P, Camara MM, et al. A multifunctional bispecific antibody protects against Pseudomonas aeruginosa. Sci Transl Med. 2014; 6: 262ra155. doi:10.1126/scitranslmed.3009655 PMID: 25391481.
28. Lindorfer MA, Nardin A, Foley PL, Solga MD, Bankovich AJ, Martin EN, et al. Targeting of Pseudomonas aeruginosa in the bloodstream with bispecific monoclonal antibodies. J Immunol. 2001; 167: 2240- 2249. PMID: 11490011.
29. De Bernardis F, Liu H, O'Mahony R, La Valle R, Bartollino S, Sandini S, et al. Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis. J Infect Dis. 2007; 195: 149-157. PMID: 17152019.
30. Yang Z, Schmidt D, Liu W, Li S, Shi L, Sheng J, et al. A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice. J Infect Dis. 2014; 210: 964-972. doi:10.1093/infdis/jiu196 PMID: 24683195.
31. Hellwig SM, van Spriel AB, Schellekens JF, Mooi FR, van de Winkel JG. Immunoglobulin A-mediated protection against Bordetella pertussis infection. Infect Immun. 2001; 69: 4846-4850. PMID: 11447159.
32. Kulshreshtha P, Bhatnagar R. Inhibition of anthrax toxins with a bispecific monoclonal antibody that cross reacts with edema factor as well as lethal factor of Bacillus anthracis. Mol Immunol. 2011; 48: 1958-1965. doi:10.1016/j.molimm.2011.05.024PMID: 21704379.
33. Wagstaffe SJ, Hill KE, Williams DW, Randle BJ, Thomas DW, Stephens P, et al. Bispecific antibodymediated detection of the Staphylococcus aureus thermonuclease. Anal Chem. 2012; 84: 5876-5884. doi:10.1021/ac203403d PMID: 22650421.
34. Guttikonda S, Tang XL, Yang BM, Armstrong GD, Suresh MR. Monospecific and bispecific antibodies against E. coli O157 for diagnostics. J Immunol Methods. 2007; 327: 1-9. PMID: 17804009.
35. Sarkar S, Tang XL, Das D, Spencer JS, Lowary TL, Suresh MR. A bispecific antibody based assay shows potential for detecting tuberculosis in resource constrained laboratory settings. PLoS One. 2012; 7: e32340. doi:10.1371/journal.pone.0032340 PMID: 22363820.
36. Arvanitis M, Anagnostou T, Fuchs BB, Caliendo AM, Mylonakis E. Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev. 2014; 27: 490-526. doi:10.1128/CMR.00091-13 PMID: 24982319.
37. La Valle R, Sandini S, Gomez MJ, Mondello F, Romagnoli G, Nisini R, et al. Generation of a recombinant 65-kilodalton mannoprotein, a major antigen target of cell-mediated immune response to Candida albicans. Infect Immun. 2000; 68: 6777-6784. PMID: 11083795.
38. Gramer MJ, van den Bremer ET, van Kampen MD, Kundu A, Kopfmann P, Etter E, et al. Production of stable bispecific IgG1 by controlled Fab-arm exchange: scalability from bench to large-scale manufacturing by application of standard approaches. MAbs. 2013; 5: 962-973. PMID: 23995617.
39. Owais M, Kazmi S, Tufail S, Zubair S. An alternative chemical redox method for the production of bispecific antibodies: implication in rapid detection of food borne pathogens. PLoS One. 2014; 9: e91255. doi:10.1371/journal.pone.0091255 PMID: 24637674.
40. Strop P, Ho WH, Boustany LM, Abdiche YN, Lindquist KC, Farias SE, et al. Generating bispecific human IgG1 and IgG2 antibodies from any antibody pair. J Mol Biol. 2012; 420: 204-219. doi:10.1016/j.jmb.2012.04.020 PMID: 22543237.
41. Spiess C, Merchant M, Huang A, Zheng Z, Yang NY, Peng J, et al. Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodies. Nat Biotechnol. 2013; 31: 753-758. doi:10.1038/nbt.2621 PMID: 23831709.
42. Labrijn AF, Meesters JI, de Goeij BE, van den Bremer ET, Neijssen J, van Kampen MD, et al. Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange. Proc Natl Acad Sci U S A. 2013; 110: 5145-5150. doi:10.1073/pnas.1220145110 PMID: 23479652.
43. Torres M, Casadevall A. The immunoglobulin constant region contributes to affinity and specificity. Trends Immunol. 2008; 29: 91-97. doi:10.1016/j.it.2007.11.004 PMID: 18191616.
44. Xia Y, Janda A, Eryilmaz E, Casadevall A, Putterman C. The constant region affects antigen binding of antibodies to DNA by altering secondary structure. Mol Immunol. 2013; 56: 28-37. doi:10.1016/j.molimm.2013.04.004 PMID: 23665381.
45. Yang CC, Chan HL. Preparation and characterization of beta 1-bungarotoxin bispecific monoclonal antibody. Biochem Mol Biol Int. 1999; 47: 1039-1048. PMID: 10410250.
46. Dmitriev DA, Massino YS, Segal OL, Smirnova MB, Kolyaskina GI, Pavlova EV, et al. The comparison of the ability of monoclonal antibodies directed to different proteins (human IgG, human myoglobin and HRP) and bispecific antibodies derived thereof to bind antigens immobilized on a surface of a solid phase. Clin Chim Acta. 2001; 309: 57-71. PMID: 11408007.
47. Harms BD, Kearns JD, Iadevaia S, Lugovskoy AA. Understanding the role of cross-arm binding efficiency in the activity of monoclonal and multispecific therapeutic antibodies. Methods. 2014; 65: 95- 104. doi:10.1016/j.ymeth.2013.07.017 PMID: 23872324.